VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Transient elastography & other techniques | Raj Vuppalanchi, MBBSView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017MRI; what can it deliver | Claude Sirlin, MDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Circulating nucleic acids and combination panels | Sven Francque, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Role of genetic assessments | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Collaboration in action - Innovative Medicines Initiative | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Collaboration in action - Foundation for the National Institutes of Health | Roberto Calle, MD, FACE, FACPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Innovation in histological assessment of NASH | Pierre Bedossa, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Opening lecture: A pathologist, a radiologist and a hepatologist walked into a bar | Brent Neuschwander-Tetri, MDView Video
ASArun SanyalMD, MBBSSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Integrated assessment of diabetes, cardiovascular and liver risks and its potential application in the clinical management of NAFLD- Arun Sanyal, MD, MBBSView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Navigating NASH biomarkers: From discovery to clinical practice- John Sninsky, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis- Sven FrancqueView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy- Pablo OrtizView Slideset
